Randomised comparative clinical study to evaluate the efficacy of rohitaka-haritaki churna and guduchyadi churna in the management of yakritodara with special reference to fatty liver disease
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Relief in sign and symptoms.
研究概览
简要总结
RANDOMISED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF ROHITAKA-HARITAKI CHURNA AND GUDUCHYADI CHURNA IN THE MANAGEMENT OF YAKRITODARA W.S.R. TO FATTY LIVER DISEASE There will be two group in the study. In Group A randomly selected and clinically diagnosed 30 patient of Yakritodara will be given Rohitaka-haritaki churna twice a day after meal. In Group B randomly selected and clinically diagnosed 30 patient of Yakritodara will be given Guduchyadi churna twice a day after meal. Both trial will be conduct for a period of 2 months. Follow up of the case will be after 15 days that is four time during treatment. Final assesment will be done after completion of two month course on the basis of subjective and laborateral assesment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •CRITERIA OF INCLUSION 1.Age group between 18 to 70 years of either sex.
- •2.Sonologically diagnosed cases of fatty liver.
- •3.Patients who agree for the trial and fill the consent form.
排除标准
- •CRITERIA OF EXCLUSION 1.Patients below the age of 18 years and above 70 years..
- •2.Grade 4 fatty liver.
- •3.Pregnant and lactating females.
- •4.Life threatening conditions [e.g. liver carcinoma] 5.Patients having portal hypertension.
- •6.Patients having ascites and liver cirrhosis.
结局指标
主要结局
Relief in sign and symptoms.
时间窗: 60 days
次要结局
- USG whole abdomen, LFT (SGOT, SGPT), BMI, LIPID PROFILE (Serum Cholesterol, Serum Triglyceride), FBS will be analysed.(60 days)
研究者
Mamta sirvi
Madan mohan malviya government ayurved college udaipur